NEW DELHI (Reuters) – Dozens of India’s technology startups band together to consider ways to challenge the US tech giant, including filing complaints with the government and courts over the local dominance …
Read More »
LONDON (Reuters) – A major non-profit health emergency group has established a global laboratory network to assess data for potential COVID-19 vaccines, allowing scientists and drug manufacturers to compare them and select …
Read More »
By Marissa Taylor, Dan Levine WASHINGTON (Reuters) – The US Food and Drug Administration has broadened its investigation into a critical illness in AstraZeneca PLC’s COVID-19 vaccine study and will look at …
Read More »
Johannesburg (Reuters) – Experts in Africa’s highly public health system, lack of testing facilities and congested slums predicted a disaster when COVID-19 hit the continent in February. FILE PHOTO: A health worker …
Read More »
WASHINGTON (Reuters) – The Trump administration will ban WeChat and the video-sharing app TikTok from the American App Store starting Sunday night, a move that would prevent Americans from downloading Chinese-owned platforms, …
Read More »
By Marissa Taylor, Dan Levine (Reuters) – Pfizer Inc. is betting that its coronovirus vaccine candidate will show early evidence of effectiveness in its clinical trial, according to company and internal documents …
Read More »
By Marissa Taylor, Dan Levine (Reuters) – Pfizer Inc. is betting that its coronovirus vaccine candidate will show early evidence of effectiveness in its clinical trial, according to company and internal documents …
Read More »
By Marissa Taylor, Dan Levine (Reuters) – Pfizer Inc. is betting that its coronovirus vaccine candidate will show early evidence of effectiveness in its clinical trial, according to company and internal documents …
Read More »
By Marissa Taylor, Dan Levine (Reuters) – Pfizer Inc. is betting that its coronovirus vaccine candidate will show early evidence of effectiveness in its clinical trial, according to company and internal documents …
Read More »
(Reuters) – US manufacturers are steadily increasing production of cheaper, faster – but less accurate – COVID-19 tests, aimed at 100 million per month by the end of the year, significantly testing …
Read More »